4//SEC Filing
GLECKEL LOUIS MD 4
Accession 0001493152-25-007199
CIK 0000868278other
Filed
Feb 17, 7:00 PM ET
Accepted
Feb 18, 5:00 PM ET
Size
5.6 KB
Accession
0001493152-25-007199
Insider Transaction Report
Form 4
GLECKEL LOUIS MD
10% Owner
Transactions
- Award
Option (right to buy)
2025-02-14+100,000→ 100,000 totalExercise: $0.60Exp: 2032-02-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeother
Related Parties
1- filerCIK 0001164762
Filing Metadata
- Form type
- 4
- Filed
- Feb 17, 7:00 PM ET
- Accepted
- Feb 18, 5:00 PM ET
- Size
- 5.6 KB